Trump’s COVID-19 treatment developed using cells originally drawn from fetal tissue
5 years ago 1 min read
The experimental Regeneron antibody treatment used to treat President Trump for COVID-19 was developed using cells originally derived from fetal tissue.
More Stories
Record Korean Cases; Trader’s Guide to Rollout: Virus Update
California Hits Record; Trader’s Guide to Rollout: Virus Update
AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push